Alinda G. Vos

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 717 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 260 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Cross-sectional study of the health of southern African truck drivers

Samanta Tresha Lalla‐Edward, Alex Emilio Fischer, François Venter et al. · BMJ Open · 2019 · 57 citations · Full text

Public Health, Community Health, Health Sciences +17

Hypertension in a rural community in South Africa: what they know, what they think they know and what they recommend

Vita W. Jongen, Samanta Tresha Lalla‐Edward, Alinda G. Vos et al. · BMC Public Health · 2019 · 56 citations · Full text

Public Health, Community Health, Health Promotion +17

Diagnosis and treatment of tuberculous uveitis in a low endemic setting

Alinda G. Vos, M.W.M. Wassenberg, Joeri de Hoog et al. · International Journal of Infectious Diseases · 2013 · 40 citations · Full text

Public Health, Infectious Diseases, Ophthalmology +16